Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Oncophage enters fast track development

Oct. 16, 2001

New clinical data show Multikine's ability to eliminate HPV-induced cervical dysplasia

Oct. 15, 2001

Favorable OvaRex/chemotherapy clinical trial results in relapsed ovarian cancer reported by AltaRex

Oct. 15, 2001

Fully humanized antibody for diagnosis and therapy of cancer

Oct. 10, 2001

Lorus and Faulding establish Virulizin distribution agreement for Latin America

Oct. 10, 2001

FDA grants orphan drug designation to Celgene's Revimid for multiple myeloma

Oct. 9, 2001

Campath trial for T-PLL yields promising results

Oct. 2, 2001

Pharmexa cleared to begin phase I/II breast cancer trial in the U.K.

Sep. 28, 2001

New DNA vaccine provides both tumor-specific immunity and antiangiogenesis

Sep. 25, 2001

Allovectin-7 phase III registration trial in metastatic melanoma now fully enrolled

Sep. 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...